GEN ILACGEN ILACGEN ILAC

GEN ILAC

No trades
See on Supercharts
Market capitalization
‪17.19 B‬TRY
‪454.58 M‬TRY
‪8.15 B‬TRY
‪72.63 M‬
Beta (1Y)
0.85

About GEN ILAC

Headquarters
Ankara
Employees (FY)
622
Founded
1998
ISIN
TREGENL00024
FIGI
BBG011QRRP85
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. It offers drugs against endocrinology, neurology, onco-haematology , nephrology, and metabolism disorders. Its products include Cajex, Contra-K, Epamor, Ferint, Genium, Genkort, Intrafen, Ilopera, Novils, Parigen, Pleksor, and Vorigen. The company was founded in 1998 and is headquartered in Ankara, Turkey.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GENIL is 58.00 TRY — it has increased by 2.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange GEN ILAC stocks are traded under the ticker GENIL.
GENIL stock is 3.96% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is GEN ILAC there?
Yes, you can track GEN ILAC financials in yearly and quarterly reports right on TradingView.
GENIL stock has fallen by 6.53% compared to the previous week, the month change is a 19.83% fall, over the last year GEN ILAC has showed a 20.18% increase.
GENIL net income for the last quarter is ‪−132.16 M‬ TRY, while the quarter before that showed ‪316.65 M‬ TRY of net income which accounts for −141.74% change. Track more GEN ILAC financial stats to get the full picture.
Today GEN ILAC has the market capitalization of ‪16.95 B‬, it has decreased by 8.41% over the last week.
Yes, GENIL dividends are paid annually. The last dividend per share was 1.11 TRY. As of today, Dividend Yield (TTM)% is 1.97%. Tracking GEN ILAC dividends might help you take more informed decisions.
GEN ILAC dividend yield was 2.37% in 2023, and payout ratio reached 73.33%. The year before the numbers were 2.15% and 30.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GENIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GEN ILAC stock right from TradingView charts — choose your broker and connect to your account.
GENIL reached its all-time high on Mar 20, 2024 with the price of 84.50 TRY, and its all-time low was 11.80 TRY and was reached on Aug 5, 2021.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 622.00 employees. See our rating of the largest employees — is GEN ILAC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GEN ILAC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GEN ILAC stock shows the buy signal. See more of GEN ILAC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GEN ILAC EBITDA is ‪767.99 M‬ TRY, and current EBITDA margin is 10.61%. See more stats in GEN ILAC financial statements.